Related Experiment Videos
Reply to Srivastava et al., "pH Conditions under Which Pyrazinamide Works in Humans"
Russell R Kempker1, Charles A Peloquin2, Henry M Blumberg3,4
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA rkempke@emory.edu.
Antimicrobial Agents and Chemotherapy
|August 26, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Incidence of and Risk Factors for Tuberculosis Among Patients Treated for Hepatitis C: a Population-based Cohort Study.
Open forum infectious diseases·2026
Tongue swab Xpert MTB/RIF Ultra for tuberculosis diagnosis in Ethiopian prisons.
Microbiology spectrum·2026
Ethionamide versus ethambutol-containing first-line regimens for TB meningitis.
Antimicrobial agents and chemotherapy·2026
Effectiveness of benznidazole in the treatment of Chagas disease in children and adults: a long-term retrospective cohort study.
Antimicrobial agents and chemotherapy·2026
Development of a dosing algorithm integrating pharmacogenetic markers and inflammation for individualization of initial voriconazole maintenance doses.
Antimicrobial agents and chemotherapy·2026
Comparative adjuvant therapy to reduce vancomycin-associated nephrotoxicity in an animal model.
Antimicrobial agents and chemotherapy·2026
Repeated emergence and fitness heterogeneity of KPC-33 in ST11 Klebsiella pneumoniae under ceftazidime-avibactam pressure.
Antimicrobial agents and chemotherapy·2026
Rapid broad-spectrum activity of molecular iodine against multidrug-resistant bacterial and fungal pathogens without residual staining.
Antimicrobial agents and chemotherapy·2026
Cardiovascular Effects of Chronic GIPR and GLP-1R Agonism in Lean and Diet-Induced Obese Mice: Sex Differences and Dose-Dependent Remodeling.
American journal of physiology. Heart and circulatory physiology·2026
Postbiotic Metabolites: Therapeutic Potential, Industrial Applications, Market Dynamics, and Regulatory Frameworks.
Probiotics and antimicrobial proteins·2026